Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study

Int J Methods Psychiatr Res. 2024 May;33(S1):e2011. doi: 10.1002/mpr.2011.

Abstract

Objectives: To estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time.

Methods: We conducted a national phone survey of 5,195 Qatari and Arab residents in Qatar (2019-2022) using the Composite International Diagnostic Interview Version 3.3 and estimated lifetime mood and anxiety defined diagnoses. Survival-based discrete time models, lifetime morbid risk, and treatment projections were estimated.

Results: Lifetime prevalence of any disorder was 28.0% and was associated with younger cohorts, females, and migrants, but lower formal education. Treatment contact in the year of disorder onset were 13.5%. The median delay in receiving treatment was 5 years (IQR = 2-13). Lifetime treatment among those with a lifetime disorder were 59.9% for non-healthcare and 63.5% for healthcare; it was 68.1% for any anxiety and 80.1% for any mood disorder after 50 years of onset. Younger cohorts and later age of onset were significantly predictors of treatment.

Conclusions: Lifetime prevalence of mental disorders in Qatar is comparable to other countries. Treatment is significantly delayed and delivered largely in non-healthcare sectors thus the need for increased literacy of mental illness to reduce stigma and improve earlier help-seeking in healthcare settings.

Keywords: 5th edition (DSM‐5); Qatar; diagnostic and statistical manual; lifetime prevalence; lifetime treatment; mental disorder.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anxiety Disorders* / epidemiology
  • Anxiety Disorders* / therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mood Disorders* / epidemiology
  • Mood Disorders* / therapy
  • Prevalence
  • Qatar / epidemiology
  • Young Adult